Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Get the Deal
Claim MarketBeat All Access Sale Promotion

CT Global Managed Portfolio Growth (CMPG) Competitors

GBX 309.90 +1.90 (+0.62%)
As of 05/22/2026 09:55 AM Eastern

CMPG vs. IHP, VEIL, BPCR, GSS, and AGT

Should you buy CT Global Managed Portfolio Growth stock or one of its competitors? MarketBeat compares CT Global Managed Portfolio Growth with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CT Global Managed Portfolio Growth include IntegraFin (IHP), Vietnam Enterprise (VEIL), BioPharma Credit (BPCR), Genesis Emerging Markets Fund (GSS), and AVI Global Trust (AGT). These companies are all part of the "asset management" industry.

How does CT Global Managed Portfolio Growth compare to IntegraFin?

CT Global Managed Portfolio Growth (LON:CMPG) and IntegraFin (LON:IHP) are both small-cap financial services companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

IntegraFin has a consensus target price of GBX 423, suggesting a potential upside of 22.11%. Given IntegraFin's stronger consensus rating and higher possible upside, analysts clearly believe IntegraFin is more favorable than CT Global Managed Portfolio Growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CT Global Managed Portfolio Growth
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
IntegraFin
0 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.60

IntegraFin has a net margin of 28.60% compared to CT Global Managed Portfolio Growth's net margin of 0.00%. IntegraFin's return on equity of 27.60% beat CT Global Managed Portfolio Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
CT Global Managed Portfolio GrowthN/A N/A N/A
IntegraFin 28.60%27.60%20.29%

IntegraFin has higher revenue and earnings than CT Global Managed Portfolio Growth. CT Global Managed Portfolio Growth is trading at a lower price-to-earnings ratio than IntegraFin, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CT Global Managed Portfolio Growth£21.03M13.96N/A£17.1518.07
IntegraFin£165.40M6.92£52.54M£15.5022.35

0.6% of CT Global Managed Portfolio Growth shares are held by institutional investors. Comparatively, 44.1% of IntegraFin shares are held by institutional investors. 0.2% of CT Global Managed Portfolio Growth shares are held by insiders. Comparatively, 14.5% of IntegraFin shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, IntegraFin had 12 more articles in the media than CT Global Managed Portfolio Growth. MarketBeat recorded 12 mentions for IntegraFin and 0 mentions for CT Global Managed Portfolio Growth. IntegraFin's average media sentiment score of 1.13 beat CT Global Managed Portfolio Growth's score of 0.00 indicating that IntegraFin is being referred to more favorably in the news media.

Company Overall Sentiment
CT Global Managed Portfolio Growth Neutral
IntegraFin Positive

Summary

IntegraFin beats CT Global Managed Portfolio Growth on 12 of the 14 factors compared between the two stocks.

How does CT Global Managed Portfolio Growth compare to Vietnam Enterprise?

Vietnam Enterprise (LON:VEIL) and CT Global Managed Portfolio Growth (LON:CMPG) are both small-cap financial services companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.

CT Global Managed Portfolio Growth has lower revenue, but higher earnings than Vietnam Enterprise. CT Global Managed Portfolio Growth is trading at a lower price-to-earnings ratio than Vietnam Enterprise, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vietnam Enterprise£81.16M13.21-£4.24M£40.0019.43
CT Global Managed Portfolio Growth£21.03M13.96N/A£17.1518.07

18.3% of Vietnam Enterprise shares are owned by institutional investors. Comparatively, 0.6% of CT Global Managed Portfolio Growth shares are owned by institutional investors. 0.2% of Vietnam Enterprise shares are owned by insiders. Comparatively, 0.2% of CT Global Managed Portfolio Growth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Vietnam Enterprise's average media sentiment score of 0.00 equaled CT Global Managed Portfolio Growth'saverage media sentiment score.

Company Overall Sentiment
Vietnam Enterprise Neutral
CT Global Managed Portfolio Growth Neutral

Vietnam Enterprise has a net margin of 67.17% compared to CT Global Managed Portfolio Growth's net margin of 0.00%. Vietnam Enterprise's return on equity of 4.38% beat CT Global Managed Portfolio Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Vietnam Enterprise67.17% 4.38% -7.53%
CT Global Managed Portfolio Growth N/A N/A N/A

Summary

Vietnam Enterprise beats CT Global Managed Portfolio Growth on 7 of the 9 factors compared between the two stocks.

How does CT Global Managed Portfolio Growth compare to BioPharma Credit?

CT Global Managed Portfolio Growth (LON:CMPG) and BioPharma Credit (LON:BPCR) are both small-cap financial services companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, media sentiment, institutional ownership and earnings.

BioPharma Credit has a net margin of 92.62% compared to CT Global Managed Portfolio Growth's net margin of 0.00%. BioPharma Credit's return on equity of 11.29% beat CT Global Managed Portfolio Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
CT Global Managed Portfolio GrowthN/A N/A N/A
BioPharma Credit 92.62%11.29%4.98%

0.6% of CT Global Managed Portfolio Growth shares are held by institutional investors. Comparatively, 27.0% of BioPharma Credit shares are held by institutional investors. 0.2% of CT Global Managed Portfolio Growth shares are held by insiders. Comparatively, 0.1% of BioPharma Credit shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

BioPharma Credit has higher revenue and earnings than CT Global Managed Portfolio Growth. BioPharma Credit is trading at a lower price-to-earnings ratio than CT Global Managed Portfolio Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CT Global Managed Portfolio Growth£21.03M13.96N/A£17.1518.07
BioPharma Credit£132.06M0.08£10.42B£11.400.08

In the previous week, CT Global Managed Portfolio Growth's average media sentiment score of 0.00 equaled BioPharma Credit'saverage media sentiment score.

Company Overall Sentiment
CT Global Managed Portfolio Growth Neutral
BioPharma Credit Neutral

Summary

BioPharma Credit beats CT Global Managed Portfolio Growth on 5 of the 9 factors compared between the two stocks.

How does CT Global Managed Portfolio Growth compare to Genesis Emerging Markets Fund?

Genesis Emerging Markets Fund (LON:GSS) and CT Global Managed Portfolio Growth (LON:CMPG) are both small-cap asset management industry companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

0.6% of CT Global Managed Portfolio Growth shares are held by institutional investors. 0.2% of CT Global Managed Portfolio Growth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Genesis Emerging Markets Fund is trading at a lower price-to-earnings ratio than CT Global Managed Portfolio Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Genesis Emerging Markets Fund£250.40M0.00N/A£140.70N/A
CT Global Managed Portfolio Growth£21.03M13.96N/A£17.1518.07

In the previous week, Genesis Emerging Markets Fund's average media sentiment score of 0.00 equaled CT Global Managed Portfolio Growth'saverage media sentiment score.

Company Overall Sentiment
Genesis Emerging Markets Fund Neutral
CT Global Managed Portfolio Growth Neutral

Company Net Margins Return on Equity Return on Assets
Genesis Emerging Markets FundN/A N/A N/A
CT Global Managed Portfolio Growth N/A N/A N/A

Summary

CT Global Managed Portfolio Growth beats Genesis Emerging Markets Fund on 3 of the 5 factors compared between the two stocks.

How does CT Global Managed Portfolio Growth compare to AVI Global Trust?

AVI Global Trust (LON:AGT) and CT Global Managed Portfolio Growth (LON:CMPG) are both small-cap financial services companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, media sentiment, dividends, risk, analyst recommendations, earnings and valuation.

AVI Global Trust has higher revenue and earnings than CT Global Managed Portfolio Growth. AVI Global Trust is trading at a lower price-to-earnings ratio than CT Global Managed Portfolio Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AVI Global Trust£127.64M8.26£215.81M£28.009.41
CT Global Managed Portfolio Growth£21.03M13.96N/A£17.1518.07

In the previous week, AVI Global Trust's average media sentiment score of 0.00 equaled CT Global Managed Portfolio Growth'saverage media sentiment score.

Company Overall Sentiment
AVI Global Trust Neutral
CT Global Managed Portfolio Growth Neutral

AVI Global Trust has a net margin of 90.88% compared to CT Global Managed Portfolio Growth's net margin of 0.00%. AVI Global Trust's return on equity of 10.82% beat CT Global Managed Portfolio Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
AVI Global Trust90.88% 10.82% 7.00%
CT Global Managed Portfolio Growth N/A N/A N/A

8.0% of AVI Global Trust shares are held by institutional investors. Comparatively, 0.6% of CT Global Managed Portfolio Growth shares are held by institutional investors. 0.2% of AVI Global Trust shares are held by insiders. Comparatively, 0.2% of CT Global Managed Portfolio Growth shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

AVI Global Trust beats CT Global Managed Portfolio Growth on 6 of the 9 factors compared between the two stocks.

Get CT Global Managed Portfolio Growth News Delivered to You Automatically

Sign up to receive the latest news and ratings for CMPG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CMPG vs. The Competition

MetricCT Global Managed Portfolio GrowthAsset Management IndustryFinancial SectorLON Exchange
Market Cap£182.92M£2.40B£5.87B£3.04B
Dividend YieldN/A5.94%5.22%6.10%
P/E Ratio18.0725.2715.88365.89
Price / Sales13.961,970.46982.4687,843.39
Price / CashN/A60.1793.3527.89
Price / BookN/A1.386.577.69
Net IncomeN/A£265.53M£1.14B£5.89B
7 Day Performance0.74%0.51%0.66%8.05%
1 Month Performance3.28%1.71%1.71%2.82%
1 Year Performance22.01%13.07%19.78%77.61%

CT Global Managed Portfolio Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CMPG
CT Global Managed Portfolio Growth
N/AGBX 309.90
+0.6%
N/A+19.2%£182.92M£21.03M18.07N/A
IHP
IntegraFin
4.3786 of 5 stars
GBX 334.29
-1.2%
GBX 423
+26.5%
+9.7%£1.11B£156.80M21.573,520
VEIL
Vietnam Enterprise
N/AGBX 781
+0.6%
N/A+41.3%£1.07B£81.16M19.53N/A
BPCR
BioPharma Credit
N/AGBX 0.94
flat
N/A+8.6%£1.06B£132.06M0.08N/A
GSS
Genesis Emerging Markets Fund
N/AN/AN/AN/A£1.06B£250.40M6.181,626

Related Companies and Tools


This page (LON:CMPG) was last updated on 5/23/2026 by MarketBeat.com Staff.
From Our Partners